We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Alcon
ALC
$34.9B
| $5.63M | 0.01% |
63,829
-12,551
| -16% | -$1.13M |
|
702
ASML
ASML
$666B
| $5.62M | 0.01% |
7,012
-2,702
| -28% | -$1.94M |
|
703
Tactile Systems Technology
TCMD
$523M
| $5.59M | 0.01% |
551,561
+165,163
| +43% | +$1.89M |
|
704
Advanced Energy
AEIS
$11.5B
| $5.58M | 0.01% |
42,105
+1,141
| +3% | +$126K |
|
705
Old National Bancorp
ONB
$9.89B
| $5.55M | 0.01% |
260,070
-6,853
| -3% | -$142K |
|
|
HAPN
706
Happen Inc
HAPN
$2.13B
| $5.55M | 0.01% |
461,203
-133,148
| -22% | -$1.38M |
|
|
CPRX
707
DELISTED
Catalyst Pharmaceutical
CPRX
| $5.53M | 0.01% |
254,780
+180,296
| +242% | +$4.26M |
|
708
L3Harris
LHX
$48.8B
| $5.48M | 0.01% |
21,846
-1,115
| -5% | -$256K |
|
709
Moody's
MCO
$88.2B
| $5.48M | 0.01% |
10,916
+1,461
| +15% | +$677K |
|
710
HCA Healthcare
HCA
$90.8B
| $5.46M | 0.01% |
14,249
-12,960
| -48% | -$4.67M |
|
711
Mistras Group
MG
$613M
| $5.45M | 0.01% |
680,825
-361
| -0.1% | -$3.04K |
|
712
Napco Security Technologies
NSSC
$1.26B
| $5.39M | 0.01% |
181,646
-3,857
| -2% | -$99.2K |
|
|
SFBS
713
ServisFirst Bancshares
SFBS
$4.72B
| $5.38M | 0.01% |
138,878
-9,298
| -6% | -$343K |
|
|
SPNS
714
DELISTED
Sapiens International
SPNS
| $5.35M | 0.01% |
182,762
-13,100
| -7% | -$365K |
|
715
Starbucks
SBUX
$122B
| $5.34M | 0.01% |
58,244
-9,821
| -14% | -$851K |
|
716
Molina Healthcare
MOH
$10.4B
| $5.32M | 0.01% |
17,860
+641
| +4% | +$201K |
|
717
LendingTree
TREE
$397M
| $5.29M | 0.01% |
142,777
-26,005
| -15% | -$1.05M |
|
718
Upstart Holdings
UPST
$2.96B
| $5.28M | 0.01% |
81,598
+76,693
| +1,564% | +$3.76M |
|
719
Molson Coors Class B
TAP
$7.77B
| $5.27M | 0.01% |
109,549
+708
| +0.7% | +$39K |
|
720
BrightSpring Health Services
BTSG
$12B
| $5.2M | 0.01% |
220,455
-141,485
| -39% | -$2.95M |
|
721
Unisys
UIS
$198M
| $5.19M | 0.01% |
1,146,392
-26,540
| -2% | -$119K |
|
|
SW
722
Smurfit Westrock
SW
$25.5B
| $5.18M | 0.01% |
119,987
+119,937
| +239,874% | +$5.13M |
|
723
Ventas
VTR
$47.6B
| $5.15M | 0.01% |
81,474
+18,753
| +30% | +$1.22M |
|
724
Becton Dickinson
BDX
$51.2B
| $5.13M | 0.01% |
29,774
-57,449
| -66% | -$10.5M |
|
|
NEE.PRR
725
DELISTED
NextEra Energy, Inc. 6.926% Corporate Units
NEE.PRR
| $5.13M | 0.01% |
129,000
| – | – |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.